AZN vs SPIR · P/E 28, $288.38B cap vs rev $110.5M
AstraZeneca PLC (AZN) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the AZN and SPIR stock pages for the full models.
Not investment advice.